News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioVentrix Reports Successful First-in-Man Transcatheter Clinical Procedure With Revivent-TC™ System for Heart Failure Treatment


10/1/2013 11:07:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN RAMON, Calif. & VILNIUS, Lithuania--(BUSINESS WIRE)--BioVentrix, a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF), today announced the first-in-man use of its Revivent-TC™ Myocardial Anchoring System, via Less Invasive Ventricular Enhancement™ or the LIVE™ procedure. The successful procedure, used to reshape and reduce the left ventricle (LV), was performed on a 61-year-old man suffering from advanced HF in the interventional catheterization laboratory at Vilnius University Hospital in Vilnius, Lithuania. The procedure was performed by Dr. med. Gintaras Kalinauskas and Dr. med. Gierdrius Davidavicius, a cardiac surgery-cardiology physician team.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES